Information Journal Paper
APA:
Copy. (2019). MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells. JOURNAL OF CANCER, 10(4), 0-0. SID. https://sid.ir/paper/695130/en
Vancouver:
Copy. MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells. JOURNAL OF CANCER[Internet]. 2019;10(4):0-0. Available from: https://sid.ir/paper/695130/en
IEEE:
Copy, “MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells,” JOURNAL OF CANCER, vol. 10, no. 4, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/695130/en